Global Bio Fund

Global Bio Fund operates as a specialized venture capital fund, channeling capital into early-stage life science and bio innovation ventures. The firm distinguishes itself with a value-driven approach, actively investing in and scaling women-led health technology companies. Through its unique seed-accelerator funding model and a robust ecosystem building strategy, Global Bio Fund provides crucial support to fledgling companies at the intersection of health and digital technology.

The fund was co-founded in 2020 by Ipshita Mandal-Johnson and Giorgio Reggiani, who serve as its founding partners. Their vision for Global Bio Fund emerged from a recognition of the increasing importance of values in both societal and business contexts, specifically addressing the need for gender-smart investment within the bio innovation sector. This foundational insight drives their strategic deployment of capital and resources.

Global Bio Fund primarily serves nascent ventures within the life sciences and health technology landscape, with a particular emphasis on those led by women. The firm's overarching mission is to address critical sustainability and development challenges through pioneering bio innovation. It aims to foster a future where groundbreaking biological advancements contribute significantly to global well-being and progress.